What is the Fischer Medical Ventures Ltd share price today?

The share price of NSE:FISCHER-EQ on 01 Oct 2026 (as of 15:03:32 IST) is ₹32.99.

What is the NSE:FISCHER-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:FISCHER-EQ 52 week high low range shows a high of ₹121.7 and a low of ₹31.05.

What is the Fischer Medical Ventures Ltd market cap?

As on 01 Oct 2026, Fischer Medical Ventures Ltd market cap is ₹23406000000.

What is the shareholding pattern of Fischer Medical Ventures Ltd Stock?

The shareholding pattern of Fischer Medical Ventures Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 62.15% Foreign Institutional Investors (FII): 5.48% Domestic Institutional Investors (DII): 1.35% Mutual Funds: 0% Retail & Others: 31.02% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Fischer Medical Ventures Ltd?

The Price-to-Earnings (PE) ratio of Fischer Medical Ventures Ltd is 78.4803, and the Price-to-Book (PB) ratio is 7.3767, as on 01 Oct 2026.

Fischer Medical Ventures Share Price

29.59-0.46 (-1.53%)

-69.92% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.53%

1 Week

-2.57%

1 Month

-17.51%

3 Month

-23.32%

6 Month

-27.60%

YTD

-28.90%

1 Year

-69.92%

5 Year

10 Year

Max

-64.77%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

29.41

29.27

High

30.38

31.45

36.15

41.00

42.37

121.70

About

Fischer Chemic Ltd is a certified supplier of APIs&intermediate Herbal Medicine Food Additives Cosmetics Raw Materials Laboratory Instrument&Chemicals PVC Modifier Aquaculture equipments etc. They have two manufacturing bases located in Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENTNSE

CPPLUSNSE

AEGISLOGNSE

PREMIERENENSE

REDINGTONNSE

HONASANSE

LLOYDSENTNSE

SGMARTNSE

MMTCNSE

CELLONSE

FISCHERNSE

LTP

1W Low

1W High

Market cap (₹)

2722.6+88.2 (3.35%)

2610

2734.80

3,64,693Cr

4440.3+255.1 (6.10%)

4045.60

4620

53,565Cr

1489.1+100.2 (7.21%)

1364.80

1508.90

48,859Cr

923+27.65 (3.09%)

883.80

930

40,856Cr

401.6+21.6 (5.68%)

380.25

411.50

30,657Cr

456.55-12.15 (-2.59%)

454.15

481.20

15,222Cr

71.83-1.9 (-2.58%)

69.25

74.70

10,838Cr

768.25-7.35 (-0.95%)

758.50

797

9,815Cr

58.56+3.69 (6.72%)

52.50

8,577Cr

373.4+8.45 (2.32%)

359.50

386

8,290Cr

29.89-0.48 (-1.58%)

29.27

31.45

2,102Cr

Fischer Medical Ventures Share Price

29.59-0.46 (-1.53%)

-69.92% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years1098%

Last year179%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year1743%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-69%

Return on Equity

10 years4%

5 years4%

3 years5%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	1098%	179%
-	-	-	1743%
-	-	-	-69%
4%	4%	5%	9%

Peer Comparison

Symbol

ADANIENT

CPPLUS

AEGISLOG

PREMIERENE

REDINGTON

HONASA

LLOYDSENT

SGMART

MMTC

CELLO

FISCHER

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,722.6	₹364693 Cr	48.99	-8.91	105.06	₹9339 Cr
4,440.3	₹53565 Cr	112.23	12.07	43.69	₹368 Cr
1,489.1	₹48859 Cr	39.05	13.8	41.65	₹898 Cr
923	₹40856 Cr	24.54	10.2	45.28	₹1510 Cr
401.6	₹30657 Cr	18.02	6.22	24.36	₹1490 Cr
456.55	₹15222 Cr	61.17	2.77	8.99	₹200 Cr
71.83	₹10838 Cr	96.52	0.38	0.91	₹283 Cr
768.25	₹9815 Cr	78.94	3.62	10.96	₹111 Cr
58.56	₹8577 Cr	19.17	0.69	3.01	₹387 Cr
373.4	₹8290 Cr	26.5	3.32	17.46	₹332 Cr
29.89	₹2102 Cr	70.47	0.06	0.48	₹30 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
₹82 Cr	₹98 Cr	₹101 Cr	₹86 Cr	₹23 Cr	₹49 Cr	₹12 Cr	₹40 Cr	₹10 Cr	₹21 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹7 Cr	₹15 L	₹38 L	₹22 L	₹74 L	₹47 L
₹83 Cr	₹99 Cr	₹102 Cr	₹89 Cr	₹31 Cr	₹49 Cr	₹12 Cr	₹40 Cr	₹11 Cr	₹21 Cr
₹72 Cr	₹98 Cr	₹80 Cr	₹71 Cr	₹20 Cr	₹47 Cr	₹12 Cr	₹39 Cr	₹11 Cr	₹18 Cr
₹13 Cr	₹2 Cr	₹23 Cr	₹19 Cr	₹12 Cr	₹3 Cr	₹88 L	₹72 L	₹48 L	₹3 Cr
₹4 Cr	₹4 Cr	₹64 L	₹92 L	₹66 L	₹23 L	₹7 L	₹5 L	₹13 L	₹5 L
₹8 Cr	-₹2 Cr	₹21 Cr	₹17 Cr	₹10 Cr	₹2 Cr	₹25 L	₹38 L	₹8 L	₹3 Cr
₹4 Cr	-₹7 Cr	₹19 Cr	₹14 Cr	₹5 Cr	₹1 Cr	-₹17 L	₹46 L	-₹12 L	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹65 Cr	₹64 Cr	₹54 Cr	₹17 L
₹26 Cr	₹30 Cr	₹87 L	₹0
₹293 Cr	₹243 Cr	₹27 Cr	-₹44 L
₹293 Cr	₹243 Cr	₹27 Cr	-₹44 L
₹384 Cr	₹338 Cr	₹81 Cr	-₹27 L
₹76 L	₹34 L	₹0	₹0
₹0	₹0	₹0	₹57 L
₹26 L	₹26 L	₹0	₹0
-₹2 Cr	₹53,000	₹12 L	-₹11 L
₹27 Cr	₹17 Cr	₹1 Cr	₹0
₹99 L	₹9 L	₹0	₹0
₹26 Cr	₹17 Cr	₹1 Cr	₹47 L
—	—	—	—
₹103 Cr	₹21 Cr	₹2 Cr	₹1 L
₹23 Cr	₹23 Cr	₹2 Cr	₹3 L
₹72 Cr	₹60 Cr	₹0	₹0
₹61 Cr	₹1 Cr	₹90,000	₹0
₹258 Cr	₹105 Cr	₹4 Cr	₹5 L
₹669 Cr	₹461 Cr	₹86 Cr	₹25 L
₹72 Cr	₹60 Cr	₹0	₹57 L
—	—	—	—
₹38 Cr	₹27 Cr	₹16 Cr	₹0
₹6 Cr	₹3 Cr	₹1 Cr	₹0
₹32 Cr	₹24 Cr	₹15 Cr	₹0
₹3 Cr	₹1 Cr	₹0	₹0
₹118 Cr	₹7 Cr	₹1 Cr	₹0
₹118 Cr	₹7 Cr	₹1 Cr	₹0
₹50 Cr	₹22 Cr	₹0	₹0
₹49 Cr	₹38 Cr	₹0	₹0
₹251 Cr	₹92 Cr	₹16 Cr	₹0
—	—	—	—
₹13 Cr	₹9 Cr	₹4 Cr	₹0
₹289 Cr	₹76 Cr	₹23 Cr	₹17 L
₹25 Cr	₹255 Cr	₹38 Cr	₹4 L
₹6 Cr	₹3 Cr	₹45 L	₹0
₹86 Cr	₹26 Cr	₹5 Cr	₹4 L
₹418 Cr	₹369 Cr	₹70 Cr	₹25 L
₹160 Cr	₹263 Cr	₹67 Cr	₹20 L
₹669 Cr	₹461 Cr	₹86 Cr	₹25 L
₹5	₹48	₹15	-₹15
₹5	₹5	₹1	-₹2

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹45 Cr	₹2 Cr	₹2 Cr	₹0
₹15 Cr	₹3 Cr	₹25 L	₹0
-₹144 Cr	-₹90 Cr	-₹10 Cr	₹0
-₹84 Cr	-₹85 Cr	-₹7 Cr	₹0
-₹101 Cr	-₹86 Cr	-₹7 Cr	₹0
-₹5 Cr	-₹125 Cr	-₹31 Cr	₹0
₹14 Cr	₹315 Cr	₹37 Cr	₹0
-₹92 Cr	₹103 Cr	-₹2 Cr	₹0
₹104 Cr	₹95 L	₹4 L	₹0
₹0	₹0	₹3 Cr	₹0
₹0	₹50,000	₹0	₹0
₹12 Cr	₹104 Cr	₹95 L	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Fischer Medical Ventures Share Price

29.59-0.46 (-1.53%)

-69.92% past 1 Year

Shareholding summary

Promoters

62.15%

FII

5.48%

DII

1.35%

Others

31.02%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
62.15%	62.15%	61.80%	61.80%	61.80%	62.81%
5.48%	4.97%	4.85%	5.57%	5.55%	5.23%
1.35%	1.38%	1.36%	1.42%	1.42%	1.44%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
31.02%	31.50%	31.99%	31.21%	31.23%	30.52%

Bulk & block deals

Name

Trade Solvent Private Limited

L7 Hitech Private Limited

Anand Mohan

Mohammadzahidhussain

Ravindradadajijilte

Arunkumar

Suresh Sabanna Itkal

Omkar Ashok Shinde

Kantilal B Shah

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
22 Sep 2026	Purchase	21.21 Cr	₹32.95	64.37 L	Bulk	0.929268	NSE
22 Sep 2026	Purchase	1.01 Cr	₹32.98	3.05 L	Bulk	0.044032	NSE
22 Sep 2026	Sell	21.21 Cr	₹32.95	64.37 L	Bulk	0.929268	NSE
10 Apr 2023	Sell	1 L	₹79.80	1.26 K	Bulk	0.000182	BSE
27 Dec 2021	Purchase	93.20 K	₹93.20	1 K	Bulk	0.000144	BSE
27 Dec 2021	Sell	90.75 K	₹93.27	973	Bulk	0.00014	BSE
23 Aug 2021	Purchase	83.95 K	₹90.07	932	Bulk	0.000135	BSE
09 Mar 2018	Purchase	11.25 K	₹12.50	900	Bulk	0.00013	BSE
09 Mar 2018	Sell	12.56 K	₹12.56	1 K	Bulk	0.000144	BSE
09 Jan 2015	Purchase	77.18 K	₹2.68	28.80 K	Bulk	0.004158	BSE

Insider trading & SAST

Client name

Shankar Varadharajan & Pacs

Shankar Varadharajan & Others

Shankar Varadharajan & Pacs

Shankar Varadharajan & Others

Shankar Varadharajan & Pacs

Fmv Holdings Pte Ltd

Shankar Varadharajan

Fmv Holdings Pte Ltd

Shankar Varadharajan

Fmv Holdings Pte Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
27 Aug 2026	Promoter	Acquisition	1.91	63.06	0	—	1.33 Cr	14 Aug 2026	Pref. Allotment	44,03,08,440	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	0.07	63.08	0	—	4.54 L	17 Aug 2026	Pref. Allotment	44,07,62,650	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	1	62.66	0	—	66.32 L	12 Aug 2026	Pref. Allotment	41,56,94,314	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	1.66	63	0	—	1.13 Cr	13 Aug 2026	Pref. Allotment	42,69,72,531	SAST	29(2)	—
27 Aug 2026	Promoter	Acquisition	0.35	62.5	0	—	23 L	11 Aug 2026	Pref. Allotment	40,90,62,650	SAST	29(2)	—
18 Aug 2026	Promoter	Acquisition	0.065615	50.78	1.06 Cr	₹23.40	4.54 L	17 Aug 2026	Conversion of security	35,47,61,120	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	0.866762	12.32	14.04 Cr	₹23.40	60 L	14 Aug 2026	Conversion of security	8,60,01,530	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	1.059748	50.74	17.17 Cr	₹23.40	73.36 L	14 Aug 2026	Conversion of security	35,43,06,910	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	0.893222	12.32	14.04 Cr	₹23.40	60 L	14 Aug 2026	Conversion of security	8,60,01,530	Insider Trading	—	Equity
17 Aug 2026	Promoter	Acquisition	1.092099	50.74	17.17 Cr	₹23.40	73.36 L	14 Aug 2026	Conversion of security	35,43,06,910	Insider Trading	—	Equity

Fischer Medical Ventures Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Fischer Medical Ventures Share Price

Fischer Medical Ventures Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Fischer Medical Ventures Share Price

Fischer Medical Ventures Share Price

Oscillators

Moving averages

Fischer Medical Ventures Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Fischer Medical Ventures Share Price

Corporate Actions

Company details

Fischer Medical Ventures Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Fischer Medical Ventures Share Price

News

Fischer Medical Ventures Approves Rs 50 Crore Investment In Subsidiary Rights Issues

Fischer Medical Ventures expands Southeast Asia imaging footprint via new deployment initiative

Fischer Medical Ventures to hold analyst and investor meet on September 7

Fischer Medical Ventures subsidiary launches Clarion AI CT system in India

Fischer Medical Ventures gets CDSCO nod for Spincare wound care device

Fischer Medical Ventures informs about outcome of board meeting

Fischer Medical reports Profit after tax of Rs -8.98 Crores, in the March 2026 quarter

Fischer Medical Ventures informs about appointment of CS cum CO

Fischer Medical - Quaterly Results

Fischer Medical Ventures Q3 FY26 EBITDA Surges to Rs 21.60 Crores, Margin Expands to 21.34% YoY.

Fischer Medical Ventures Reports Q3 Net Profit of Rs 19.20 Crores, Revenue Rs 100 Crores YoY.

Fischer Medical Ventures Board Approves Restructuring of Malaysian Subsidiary Shareholding.

Fischer Medical reports Profit after tax of Rs -1.67 Crores, in the December 2025 quarter

Fischer Medical Ventures Restructures Pellucidcare Health Innovations Transfer to Subsidiary

Fischer Medical Ventures informs about reconstitution of committees

Fischer Medical Ventures informs about press release

Fischer Medical Ventures’ arm wins order worth Rs 9.29 crore

Fischer Medical Ventures informs about press release

Fischer Medical Ventures informs about audio recording of conference call

Fischer Medical Ventures informs about press release

Fischer Medical Ventures Ltd Share Price Today

Fischer Medical Ventures Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator